The economic and health burdens of diseases caused by group A Streptococcus in New Zealand

The economic and health burdens of diseases caused by group A Streptococcus in New Zealand

Objectives: In preparation for the future arrival of a group A Streptococcus (GAS) vaccine, this study estimated the economic and health burdens of GAS diseases in New Zealand (NZ). Methods: The annual incidence of GAS diseases was based on extrapolation of the average number of primary healthcare e...

Full description

Bibliographic Details
Main Authors: Jeffrey W. Cannon, Jane Zhung, Julie Bennett, Nicole J. Moreland, Michael G. Baker, Elizabeth Geelhoed, John Fraser, Jonathan R. Carapetis, Susan Jack
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:International Journal of Infectious Diseases
Subjects:
Group A Streptococcus
Rheumatic fever
Skin infections
Cellulitis
Health burden
Economic burden
Online Access:http://www.sciencedirect.com/science/article/pii/S120197122032508X

Internet

http://www.sciencedirect.com/science/article/pii/S120197122032508X

Similar Items